EGCG — Benefits Deep Dive
Epigallocatechin gallate (EGCG) is the major catechin of green tea and one of the most heavily studied plant polyphenols in human nutrition. In trials and meta-analyses, green tea and its catechins modestly nudge fat metabolism and lower LDL cholesterol by a few mg/dL and blood pressure by about 2 mmHg; in laboratory studies EGCG quiets inflammatory signaling, and it is widely investigated in cancer-prevention laboratories. But EGCG is also a compound where honest framing matters more than hype: most of its metabolic effects are small and often depend on the caffeine that rides alongside it in tea, its cancer data are overwhelmingly preclinical, and — most importantly — concentrated green tea extracts have been linked to liver injury, with fasted, high-dose use raising EGCG exposure. The European Food Safety Authority (EFSA) considers traditionally brewed green tea in general safe at the intakes reported in Europe, while EFSA and the NIH LiverTox database both report rare cases of liver injury after drinking green tea. The four deep-dive pages below separate the well-supported benefits from the overstated ones, and set out the liver-safety findings in full.
Deep-Dive Articles
Metabolism & Weight
How EGCG raises thermogenesis and fat oxidation by inhibiting catechol-O-methyltransferase and prolonging norepinephrine signaling, why the effect is small and often caffeine-dependent, what the weight-loss meta-analyses (Hursel 2009) and the Cochrane review (Jurgens 2012) actually found, and the honest bottom line: EGCG is a minor metabolic lever, not a weight-loss drug.
Read the deep dive →Heart & Cholesterol
Green tea catechins lower total and LDL cholesterol by a small but consistent margin (Zheng 2011, Kim 2011), lower systolic blood pressure by about 2 mmHg (Khalesi 2014, Peng 2014), acutely improve endothelial function (Widlansky 2007), and track with lower cardiovascular mortality in the Ohsaki cohort (Kuriyama 2006). What the numbers mean for a real person.
Read the deep dive →Antioxidant & Cellular Health
EGCG as a direct radical scavenger, a hormetic activator of the Nrf2 antioxidant-response pathway, and an inhibitor of NF-κB inflammatory signaling. Plus a careful, honest look at the enormous preclinical cancer-chemoprevention literature (Yang 2009) — strong in cells and animals, unproven in humans. EGCG does not treat or prevent cancer.
Read the deep dive →Safety & Liver
The essential caveat. EFSA considers traditionally brewed green tea in general safe at the intakes reported in Europe, though EFSA and LiverTox report rare liver-injury cases after green tea infusions. Concentrated green tea extracts have been linked to liver injury ranging from raised liver enzymes to rare acute liver failure (Mazzanti 2009, Oketch-Rabah 2020). EFSA's 800 mg/day transaminase signal, the EU 2022 limit and its label warnings, and USP's cautionary labeling.
Read the deep dive →Table of Contents
How EGCG Works — One Molecule, Many Targets
EGCG is a flavan-3-ol — a polyphenol built from a catechin backbone with a gallate ester attached. That gallate group is what makes EGCG special: it gives the molecule eight hydroxyl groups arranged so that, in laboratory studies, EGCG is both a strong direct antioxidant and a promiscuous binder of proteins. This promiscuity is the reason a single compound shows up in metabolism, cardiology, immunology, and oncology research all at once, and it is also the reason its effects are broad but individually modest.
Three mechanistic themes run through everything on the four benefit pages:
- Metabolic signaling — EGCG inhibits catechol-O-methyltransferase (COMT), the enzyme that degrades norepinephrine. By slowing that breakdown, EGCG prolongs the fat-mobilizing signal of the sympathetic nervous system. This is the biochemical basis for the thermogenesis and fat-oxidation effects — and the reason those effects are amplified by the caffeine that naturally accompanies EGCG in tea.
- Redox and gene regulation — at the low concentrations reached after drinking tea, EGCG behaves less like a simple free-radical sponge and more like a hormetic signal: a mild, transient pro-oxidant stress that switches on the cell's own Nrf2/ARE antioxidant machinery and simultaneously dampens the NF-κB inflammatory pathway. This underlies the antioxidant and anti-inflammatory effects and the large preclinical cancer-chemoprevention literature.
- Vascular and lipid effects — EGCG acutely improved endothelial function in one trial, is proposed to reduce intestinal cholesterol absorption, and green tea lowers LDL modestly in meta-analyses; together these are the small but reproducible cardiovascular findings.
EGCG's oral bioavailability is low, and taking concentrated doses on an empty stomach raises the amount absorbed: peak plasma free EGCG was more than 3.5-fold higher after an overnight fast than with a light breakfast (Chow and colleagues, 2005). USP and EFSA connect that fasted, bolus pattern with liver injury from concentrated extracts. The intake from brewed tea is not the same exposure as a concentrated extract: EFSA estimated mean EGCG intake from green tea infusions at 90–300 mg a day in European adults, while supplements supplied 5–1,000 mg a day.
Research Papers: Metabolism & Weight
- Dulloo AG et al. (1999). Efficacy of a green tea extract rich in catechin polyphenols and caffeine in increasing 24-h energy expenditure and fat oxidation in humans. Am J Clin Nutr — PubMed PMID: 10584049
- Boschmann M, Thielecke F (2007). The effects of epigallocatechin-3-gallate on thermogenesis and fat oxidation in obese men. J Am Coll Nutr — PubMed PMID: 17906192
- Hursel R et al. (2009). The effects of green tea on weight loss and weight maintenance: a meta-analysis. Int J Obes (Lond) — PubMed PMID: 19597519
- Jurgens TM et al. (2012). Green tea for weight loss and weight maintenance in overweight or obese adults. Cochrane Database Syst Rev — PubMed PMID: 23235664
- Nagao T et al. (2005). Ingestion of a tea rich in catechins leads to a reduction in body fat and malondialdehyde-modified LDL in men. Am J Clin Nutr — PubMed PMID: 15640470
- Maki KC et al. (2009). Green tea catechin consumption enhances exercise-induced abdominal fat loss in overweight and obese adults. J Nutr — PubMed PMID: 19074207
- Basu A et al. (2010). Green tea supplementation affects body weight, lipids, and lipid peroxidation in obese subjects with metabolic syndrome. J Am Coll Nutr — PubMed PMID: 20595643
Research Papers: Heart & Cholesterol
- Zheng XX et al. (2011). Green tea intake lowers fasting serum total and LDL cholesterol in adults: a meta-analysis of 14 randomized controlled trials. Am J Clin Nutr — PubMed PMID: 21715508
- Kim A et al. (2011). Green tea catechins decrease total and low-density lipoprotein cholesterol: a systematic review and meta-analysis. J Am Diet Assoc — PubMed PMID: 22027055
- Khalesi S et al. (2014). Green tea catechins and blood pressure: a systematic review and meta-analysis of randomised controlled trials. Eur J Nutr — PubMed PMID: 24861099
- Peng X et al. (2014). Effect of green tea consumption on blood pressure: a meta-analysis of 13 randomized controlled trials. Sci Rep — PubMed PMID: 25176280
- Widlansky ME et al. (2007). Acute EGCG supplementation reverses endothelial dysfunction in patients with coronary artery disease. J Am Coll Nutr — PubMed PMID: 17536120
- Kuriyama S et al. (2006). Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan: the Ohsaki study. JAMA — PubMed PMID: 16968850
Research Papers: Antioxidant, Anti-Inflammatory & Cancer Research
- Chacko SM et al. (2010). Beneficial effects of green tea: a literature review. Chin Med. — PubMed PMID: 20370896
- Singh BN, Shankar S, Srivastava RK (2011). Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications. Biochem Pharmacol. — PubMed PMID: 21827739
- Yang CS, Wang X, Lu G, Picinich SC (2009). Cancer prevention by tea: animal studies, molecular mechanisms and human relevance. Nat Rev Cancer. — PubMed PMID: 19472429
- Bettuzzi S et al. (2006). Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia. Cancer Res. — PubMed PMID: 16424063
- Yang CS, Wang H, Sheridan ZP (2018). Studies on prevention of obesity, metabolic syndrome, diabetes, cardiovascular diseases and cancer by tea. J Food Drug Anal. 26(1):1–13. — PubMed PMID: 29389543
- Chow HH et al. (2003). Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of EGCG and Polyphenon E in healthy individuals. Clin Cancer Res. — PubMed PMID: 12960117
- Chow HH et al. (2005). Effects of dosing condition on the oral bioavailability of green tea catechins after single-dose administration of Polyphenon E in healthy individuals. Clin Cancer Res 11(12):4627–4633. — PubMed PMID: 15958649
Research Papers: Safety & Liver
- Oketch-Rabah HA et al. (2020). United States Pharmacopeia (USP) comprehensive review of the hepatotoxicity of green tea extracts. Toxicol Rep. — PubMed PMID: 32140423
- Mazzanti G et al. (2009). Hepatotoxicity from green tea: a review of the literature and two unpublished cases. Eur J Clin Pharmacol. — PubMed PMID: 19198822
- Sarma DN et al. (2008). Safety of green tea extracts: a systematic review by the US Pharmacopeia. Drug Saf. — PubMed PMID: 18484782
- Hu J et al. (2018). The safety of green tea and green tea extract consumption in adults — results of a systematic review. Regul Toxicol Pharmacol. — PubMed PMID: 29580974
- Navarro VJ et al. (2017). Liver injury from herbal and dietary supplements. Hepatology. — PubMed PMID: 27677775
- Pezeshki A et al. (2016). The effect of green tea extract supplementation on liver enzymes in patients with nonalcoholic fatty liver disease. Int J Prev Med. — PubMed PMID: 26955458
- EFSA Panel on Food Additives and Nutrient Sources added to Food (ANS), Younes M et al. (2018). Scientific opinion on the safety of green tea catechins. EFSA J 16(4):e05239. — PubMed PMID: 32625874
- LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. Green Tea. National Institute of Diabetes and Digestive and Kidney Diseases (2012–). — PubMed PMID: 31643260
External Authoritative Resources
- Linus Pauling Institute — Tea Micronutrient Information Center — a scientific summary of tea and tea catechin research.
- EFSA (2018) — Scientific opinion on the safety of green tea catechins — the European Food Safety Authority opinion reporting a significant transaminase rise in trials at ≥800 mg EGCG/day and identifying no supplement intake free of concern.
- LiverTox (NIH) — Green Tea — the NIH clinical database entry on green tea extract hepatotoxicity.
- NIH Office of Dietary Supplements — Fact Sheets
- PubMed — All research on EGCG (thousands of papers).